Pierre-Marie Preux

Pierre-Marie Preux

Auto-generated profile, based on publicly available information

Pierre-Marie Preux

Inserm U1094, IRD UMR270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Global Health – Michel Dumas, OmegaHealth, Limoges, France

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2012 in Circulation
Verified
Journal Article
Closed access
VAVictor Aboyans
Victor Aboyans
MCMichael H. Criqui
Michael H. Criqui
PAPierre Abraham
Pierre Abraham
MAMatthew A. Allison
Matthew A. Allison
MCMark A. Creager
Mark A. Creager
DTDiane Treat-Jacobson
Diane Treat-Jacobson

7 September 2011 in Epilepsia
Verified
Journal Article
Open access
PDF file
DTDavid J. Thurman
David J. Thurman
EBEttore Beghi
Ettore Beghi
CBCharles E. Begley
Charles E. Begley
ABAnne T. Berg
Anne T. Berg
JBJeffrey R. Buchhalter
Jeffrey R. Buchhalter
FEFor The Ilae Commission On Epidemiology
For The Ilae Commission On Epidemiology
Summary: Worldwide, about 65 million people are estimated to have epilepsy. Epidemiologic studies are necessary to define the full public health burden of epilepsy; to set public health and health care priorities; to provide information needed for prevention, early detection, and treatment; to identify education and service needs; and to promote effective health care and support programs for people with epilepsy. However, different definitions and epidemiologic methods complicate the tasks of these studies and their interpretations and comparisons. The purpose of this document is to promote consistency in definitions and methods in an effort to enhance future population‐based epidemiologic studies, facilitate comparison between populations, and encourage the collection of data useful for the promotion of public health. We discuss: (1) conceptual and operational definitions of epilepsy, (2) data resources and recommended data elements, and (3) methods and analyses appropriate for epidemiologic studies or the surveillance of epilepsy. Variations in these are considered, taking into account differing resource availability and needs among countries and differing purposes among studies.

30 September 2015 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
AVAnnamaria Vezzani
Annamaria Vezzani
RFRobert S. Fujinami
Robert S. Fujinami
HWH. Steve White
H. Steve White
PPPierre-Marie Preux
Pierre-Marie Preux
IBIngmar Blümcke
Ingmar Blümcke
Wolfgang LöscherWolfgang Löscher
Wolfgang Löscher

1 September 1999 in Neurology
Verified
Journal Article
Closed access
PDF file
JDJ.C. Desport
J.C. Desport
PPP.M. Preux
P.M. Preux
TTT.C. Truong
T.C. Truong
JVJ.M. Vallat
J.M. Vallat
DSD. Sautereau
D. Sautereau
PCP. Couratier
P. Couratier
Objective: To evaluate the occurrence of malnutrition in patients with ALS, to assess the relation of malnutrition to the neurologic deficit, and to determine the impact of nutritional status on patient survival. Background: Although ALS may be associated with significant malnutrition, the relative impact on patient survival has not yet been well established. Methods: In a prospective 7-month study of 55 ALS patients in a referral neurology practice, nutritional status was assessed by calculating body mass index. Neurologic evaluation includes four functional scores and identifies the form of disease onset. Slow vital capacity (VC) was also measured. Results: Occurrence of malnutrition in patients studied was 16.4%. Survival (using the Kaplan–Meier method) was worse for malnourished patients (p < 0.0001), with a 7.7-fold increased risk of death. Using multivariate analysis, only reduced VC (p < 0.0001) and malnutrition (p < 0.01) were found to have significant independent prognostic value. The degree of malnutrition is independent of neurologic scores and of forms of ALS onset. Conclusion: Nutritional surveillance of ALS patients is very important, both in bulbar-onset and spinal-onset patients.

1 January 2005 in The Lancet Neurology
Verified
Journal Article
Closed access
PPPierre-Marie Preux
Pierre-Marie Preux
MDMichel Druet-Cabanac
Michel Druet-Cabanac

1 September 2001 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
JDJean C Desport
Jean C Desport
PPPierre M Preux
Pierre M Preux
LMLaurent Magy
Laurent Magy
YBYves Boirie
Yves Boirie
JVJean M Vallat
Jean M Vallat
PCPhilippe Couratier
Philippe Couratier
Background: Amyotrophic lateral sclerosis (ALS) is a severe disease characterized by neurogenic amyotrophy and degeneration of upper and lower motor neurons. Although ALS patients usually experience reductions in fat-free mass (FFM), hypermetabolism via an undetermined source has also been reported. Objective: The objective was to clarify the metabolic level of ALS patients. Design: We measured the resting energy expenditure (REE) of 62 patients (32 men and 30 women) with ALS and investigated the factors correlated with metabolic level. Nutritional evaluation included bioelectrical impedance analysis, indirect calorimetry, and calculation of the body mass index. Neurologic assessment included an evaluation of peripheral and central neurologic deficit. Forced vital capacity was measured and smoking status was noted. A complete blood cell count was made and thyroid hormone and C-reactive protein concentrations were measured. Results: Patients were hypermetabolic, by an average of ≈10% more than in a reference healthy population. FFM, age, and the neutrophil count were significantly associated with REE. The only variable that contributed to the prediction of REE, REE/Z100 kHz (bioimpedance at 100 kHz), REE adjusted for FFM, or the ratio of measured REE to calculated REE was the neutrophil count, which explained only a small percentage of variance in the multiple regression analysis. Hypermetabolism was not associated with a reduction in respiratory function, tobacco use, hyperthyroidism, spasticity and fasciculation intensities, or infection. Conclusions: Our study corroborates the surprising finding that ALS patients are hypermetabolic. FFM, age, sex, manual muscular testing, the modified Norris limb score, weight, and an increase in circulating neutrophil counts correlated with the hypermetabolic state. Other factors may play a role in pathophysiologic processes that involve mitochondrial energy production or even sympathoadrenergic activation.